171
Views
3
CrossRef citations to date
0
Altmetric
Short Communication

De novo mutation in SLC25A22 gene: expansion of the clinical and electroencephalographic phenotype

ORCID Icon, , , , , , , , & show all
Pages 67-73 | Received 14 Oct 2020, Accepted 15 Feb 2021, Published online: 06 Apr 2021
 

Abstract

The SLC25A22 (Solute Carrier Family 25, Member 22) gene encodes for a mitochondrial glutamate/H+ symporter and is involved in the mitochondrial transport of metabolites across the mitochondrial membrane. We hereby report a 12-year-old girl presenting with early-onset epileptic encephalopathy, hypotonia, and global developmental delay. Whole exome sequencing identified a novel homozygous missense mutation in SLC25A22 gene (c.97A>G; p.Lys33Glu), as the likely cause of the disease. The phenotype of our patient and EEG recordings do not completely overlap with the phenotypes previously described, leading to a new and more complex form of disease associated with SLC25A22 variants, characterized by dyskinetic movements and oculogyric crisis.

Acknowledgements

We gratefully acknowledge the family for the enthusiastic collaboration to this study.

Disclosure statement

The authors declare no conflict of interest.

Additional information

Funding

This study was supported in part by The Wellcome Trust in equipment and strategic award (Synaptopathies) [WT093205 MA and WT104033AIA].

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.